Dismay as Alzheimer’s drug fails in clinical trials – The Guardian

The Guardian

Dismay as Alzheimer's drug fails in clinical trials
The Guardian
In a statement, the company said: “Lilly will not pursue regulatory submissions for solanezumab for the treatment of mild dementia due to Alzheimer's disease.” Lilly's shares plunged 14% on Wednesday before markets opened. The same drug failed in a ...
Promising Alzheimer's Drug Doesn't Help Dementia PatientsNBCNews.com
Alzheimer's drug 'disappointment': Widely anticipated drug to treat disease fails in trialExpress.co.uk
Eli Lilly's Experimental Alzheimer's Drug Failed in Large TrialNew York Times
USA TODAY -BBC News -Daily Mail -Eli Lilly and Company
all 202 news articles »